Our recent recommendation that you might want to skip the new weight-loss drug Belviq has generated a lot of buzz. To follow up, we commissioned two Dartmouth professors to look at the evidence and prepare a Drug Facts box for Belviq, ...
Tags: Belviq, Weight-Loss Drug, Health&Medicine
A year after receiving approval by the Food and Drug Administration, the new weight-loss drug Belviq is finally available by prescription. But you may not want to rush out and get it. It's only approved for people who are obese, with a ...
Eisai has announced the availability of Belviq (lorcaserin HCl) CIV tablets in the US, which is designed for chronic weight management in adults who are overweight with a comorbidity or obesity. Indicated for people with body mass ...
Tags: Eisai, Weight Management Therapy
Eisai's subsidiary Eisai Laboratorios has submitted a marketing authorization application (MAA) for Belviq (lorcaserin HCl) with the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico. Arena Pharmaceuticals's ...
Tags: Eisai, Mexican Marketing, Belviq
Arena Pharmaceuticals and Eisai have announced FDA approval of Belviq (lorcaserin HCl) for chronic weight management in adults who are overweight with comorbidity or obese. The FDA approved Belviq as an adjunct to a reduced-calorie diet ...
Tags: Belviq, lorcaserin HCl, chronic weight management, Arena Pharmaceuticals